EYLEA 114.3 mg/ml, solution for injection bottle, 0.263 ml + 1 needle
Active ingredients: Aflibercept
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionbottle, 0.263 ml + 1 needleintravitréenne
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- EYLEA 114,3 mg/mL, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intravitréenne
- Presentation description
- 1 flacon en verre de 0,263 ml + 1 aiguille à filtre
- Marketing authorisation holder
- BAYER AG (ALLEMAGNE)
- Reimbursement according to BDPM
- 100%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 30 Sept 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69166985CIP73028332CIP133400930283325Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| AFLIBERCEPTsolution | 114,3 mg · 1 mL de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.